For the discovery of CoV-2 particle entry in absence of ACE2 and genome-wide gain-of-function screening to identify new secondary receptors/co-receptors/auxiliary proteins that facilitate viral entry/fusion.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Patrick GiguèreResearch Location
CanadaLead Research Institution
University of OttawaResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
For the discovery of CoV-2 particle entry in absence of ACE2 and genome-wide gain-of-function screening to identify new secondary receptors/co-receptors/auxiliary proteins that facilitate viral entry/fusion.